US Stocks
/
Tvardi Therapeutics, Inc. Share Price

Tvardi Therapeutics, Inc. Share Price

NASDAQ: TVRD | Micro Cap
$1.76
-$0.10 (-5.11%) Last updated on 11 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Tvardi Therapeutics, Inc. Stock Performance

Open
$1.84
Prev. Close
$1.86
Circuit Range
N/A
Day Range
$1.72 - $1.84
Year Range
$1.67 - $43.27
Volume
3,849
Average Traded
$1.79

Tvardi Therapeutics, Inc. Share Price Today

As of 11 August 2026, Tvardi Therapeutics, Inc.'s share price is $1.76. The stock opened at $1.84, compared to its previous close of $1.86. During today's trading session, Tvardi Therapeutics, Inc.'s share price traded between $1.72 and $1.84, with an average price of $1.78. Over the past 52 weeks, the stock has recorded a high of $43.27 and a low of $1.67. In terms of performance, Tvardi Therapeutics, Inc.'s share price has declined by 55.65% over the last six months and is down 94.20% on a year-on-year basis.

Tvardi Therapeutics, Inc. Share Price Chart

$1.72$1.84
L
Show Current Price
H

Tvardi Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$13.09M
PE Ratio (TTM)
-0.72
Dividend Yield
N/A
EPS (TTM)
$-2.46
Revenue (TTM)
$7.14M
Return On Equity (TTM)
-86.96%
Profit Margin
-255.21%
Debt to Equity
0.53
Quarterly Earnings Growth YoY
84.02%

Tvardi Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025
RevenueN/A$991000.00$2.56M$2.57M
Net Profit-$30.70M-$20.02M-$12.48M-$4.91M
Net Profit MarginN/A-2019.78%-488.11%-190.97%
Income ChangeN/A34.79%37.67%60.68%

Tvardi Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2021202220232024
Revenue$23.03M$41.87M$20.97M$7.14M
Net Profit-$88.44M-$85.47M-$118.51M-$70.87M
Net Profit Margin-384.06%-204.16%-565.21%-992.95%
Income ChangeN/A3.35%-38.65%40.20%

About Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc. operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases. It develops inhibitors of STAT3, a molecule implicated in the initiation and progression of cancer and fibrosis. Its pipeline includes TTI-101, a small-molecule inhibitor of signal transducers and activators of transcription; and TTI-109, a STAT3 inhibitor for clinical use, including tolerability, bioavailability, and potency. Tvardi Therapeutics, Inc. was incorporated in 2017 and is based in Sugar Land, Texas.

Tvardi Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$2.06
$1.88
-10.90%
Jul 2026
$1.86
$2.11
+9.61%
Jun 2026
$3.33
$1.93
-43.22%
May 2026
$3.13
$3.39
+8.31%
Apr 2026
$3.11
$3.13
-1.57%
Mar 2026
$4.11
$3.18
-20.10%
Feb 2026
$3.93
$3.98
+0.76%
Jan 2026
$4.26
$3.95
-8.35%
Dec 2025
$4.08
$4.31
+4.48%
Nov 2025
$4.63
$4.13
-11.58%
Oct 2025
$38.81
$4.67
-88.11%
Sep 2025
$29.73
$39.24
+29.07%

TVRD Share Price FAQs

What is Tvardi Therapeutics, Inc. share price today?

chevron-up
Tvardi Therapeutics, Inc. share price today is $1.76 as on August 11, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Tvardi Therapeutics, Inc. stock?

chevron-up
The 52 week high of Tvardi Therapeutics, Inc. stock is $43.27, while the 52 week low is $1.67 as of 11 Aug '26.

What is TVRD's market capitalisation today?

chevron-up
TVRD market capitalisation is $13.09M as of August 11, 2026, at 3:54 pm IST.

What is TVRD's net income for the last quarter?

chevron-up
TVRD's net income for the last quarter is -0.00B USD.

What is the 5 year returns of TVRD?

chevron-up
The 5 year returns of TVRD is -99.69% as on 11 Aug '26.

What is the high & low stock price of TVRD today?

chevron-up
TVRD stock price hit a high of $1.84 and low of $1.72 as of 11 Aug '26.

Can I buy TVRD shares in India?

chevron-up
Yes. You can buy TVRD in India by opening an international trading account.